A survey of heparin monitoring in australasia
- 1 January 1996
- Vol. 28 (4) , 343-347
- https://doi.org/10.1080/00313029600169314
Abstract
Full dose heparin therapy is monitored by a variety of laboratory methods, of which the activated partial thromboplastin time (APTT) is the most popular. A large number of APTT reagents are currently available, with different sensitivities to heparin evident in many. Within the literature it is apparent that there is a lack of consensus, and indeed some confusion, regarding the therapeutic ranges for the APTT for standard heparin therapy in the treatment of venous thromboembolic disease. Accordingly we conducted an Australasian survey to evaluate current laboratory and clinical practices in monitoring heparin therapy, to determine the extent of variation in the approach and to stimulate the process of standardisation of acceptable procedures and methodology. Results of the survey demonstrate that currently there is no uniform practice used to establish therapeutic ranges for monitoring standard heparin therapy. Furthermore, results suggest that current practice may lead to subtherapeutic anticoagulation in many laboratories.Keywords
This publication has 12 references indexed in Scilit:
- Establishing a Therapeutic Range for Heparin TherapyAnnals of Internal Medicine, 1993
- 10 Anticoagulant therapy in venous thromboembolismBailliere's Clinical Haematology, 1990
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Comparison of Two APTT Methods of Monitoring Heparin Therapy: APTT Ratio and Heparin Response of Pooled Normal PlasmaAmerican Journal of Clinical Pathology, 1990
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Heparin Monitoring by Activated Partial Thromboplastin Time: Comparison of Ex Vivo Measurement and In Vitro Standardization.American Journal of Clinical Pathology, 1985
- Heparin and the Activated Partial Thromboplastin Time — A Difference between theIn-vitroandIn-vivoEffects and Implications for the Therapeutic RangeAmerican Journal of Clinical Pathology, 1980
- Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosisBlood, 1977
- A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin TimeNew England Journal of Medicine, 1972